Reference : Factors predicting the probability of relapse after discontinuation of migraine preve...
Scientific journals : Article
Social & behavioral sciences, psychology : Neurosciences & behavior
Human health sciences : Neurology
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate.
Schoenen, Jean mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Neuro-anatomie >]
Reuter, Uwe [> > > >]
Diener, Hans*-Christoph [> > > >]
Pfeil, Joop [> > > >]
Schwalen, Susanne [> > > >]
Schauble, Barbara [> > > >]
van Oene, Joop [> > > >]
Cephalalgia : An International Journal of Headache
Blackwell Science
Yes (verified by ORBi)
Osney Mead Oxford
United Kingdom
[en] INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlonged Migraine Prevention with Topiramate (PROMPT) study to determine potential contribution to relapse. METHODS: After a six-month open-label (OL) topiramate phase, patients were randomised to continue topiramate or switch to placebo in a six-month double-blind (DB) phase. 'Relapse' was investigated in terms of change in monthly migraine days after randomisation compared with the month before randomisation, and was analysed during the first ('initial relapse') and last month ('sustained relapse') of the DB phase. More than 40 potential predicting factors were entered into analyses of variance and covariance. RESULTS: For initial relapse, variable-by-treatment interactions were significant for the Headache Impact Test (HIT-6) at DB baseline, and decline in acute medication intake or reporting of 'anxiety' in the OL phase. For sustained relapse, no statistically significant interactions were observed. CONCLUSION: Relapse after topiramate discontinuation in migraine prophylaxis appears to be unaffected by patient characteristics or baseline migraine frequency.

File(s) associated to this reference

Fulltext file(s):

Restricted access
Factors predicting Schoenen et al 2010.pdfPublisher postprint239.17 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.